Gutsy Learing Series text with people in an audience

The IBD Treatment Landscape: TL1A and Small Molecule Advanced Therapies

The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ...

 • 
Virtual
 • 
People walking at a Gutsy Walk park

Gutsy Walk 2026: 30 years walking to stop Crohn’s and colitis

Gutsy Walkers—get ready for 2026! Crohn’s and Colitis Canada’s annual fundraiser is set for Sunday, May 31, in Toronto, and Sunday, June 7, 2026, across Canada. Gutsy Walk is now ...

 • 
Check the Gutsy Walk website for a walk location near you
 • 
Remember to bookmark this page.

Search by Postal Code

News

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Crohn’s and Colitis Canada and Pfizer Canada Announce 2022 Women in IBD Award Recipients

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada

 20 21 22 23 24 25 26 27 28 29